The prognosis of periprocedural myocardial infarction after percutaneous coronary interventions

Cardiovascular Revascularization Medicine

Volumn 14, Issue 1, 2013, Pages 32-36

  Zimarino, Marco ^a   Affinito, Vincenzo ^b  

^a Center of Excellence on Aging   (Italy)

^b Bambin Gesù Pediatric Cardiology Hospital   (Italy)

Author keywords

Coronary angioplasty; Periprocedural myocardial infarction; Stent

Indexed keywords

CREATINE KINASE ISOENZYME; EPTIFIBATIDE; PRASUGREL; TROPONIN; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; CARDIOVASCULAR MORTALITY; ELECTROCARDIOGRAM; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PERIPROCEDURAL MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; UNSTABLE ANGINA PECTORIS;

BIOLOGICAL MARKERS; CREATINE KINASE, MB FORM; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; STENTS; TROPONIN; UP-REGULATION;

EID: 84872554815     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2012.10.006     Document Type: Review

References (43)

1. Califf R.M., Abdelmeguid A.E., Kuntz R.E., Popma J.J., Davidson C.J., Cohen E.A., et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998, 31:241-251.
2. Nallamothu B.K., Chetcuti S., Mukherjee D., Grossman P.M., Kline-Rogers E., Werns S.W., et al. Prognostic implication of troponin I elevation after percutaneous coronary intervention. Am J Cardiol 2003, 91:1272-1274.
3. Kini A.S., Lee P., Marmur J.D., Agarwal A., Duffy M.E., Kim M.C., et al. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol 2004, 93:18-23.
4. Natarajan M.K., Kreatsoulas C., Velianou J.L., Mehta S.R., Pericak D., Goodhart D.M. Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions. Am J Cardiol 2004, 93:750-753.
5. Cavallini C., Savonitto S., Violini R., Arraiz G., Plebani M., Olivari Z., et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J 2005, 26:1494-1498.
6. Miller W.L., Garratt K.N., Burritt M.F., Lennon R.J., Reeder G.S., Jaffe A.S. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J 2006, 27:1061-1069.
7. Nienhuis M.B., Ottervanger J.P., Bilo H.J., Dikkeschei B.D., Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv 2008, 71:318-324.
8. Prasad A., Rihal C.S., Lennon R.J., Singh M., Jaffe A.S., Holmes D.R. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv 2008, 1:10-19.
9. De Labriolle A., Lemesle G., Bonello L., Syed A.I., Collins S.D., Ben-Dor I., et al. Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery. Am J Cardiol 2009, 103:639-645.
10. Feldman D.N., Minutello R.M., Bergman G., Moussa I., Wong S.C. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes. Am J Cardiol 2009, 104:1210-1215.
11. Gomez-Hospital J.A., Cequier A., Valero J., Gonzalez-Costello J., Manas P., Iraculis E., et al. Minor myocardial damage during percutaneous coronary intervention does not affect long-term prognosis. Rev Esp Cardiol 2009, 62:625-632.
12. Milani R.V., Fitzgerald R., Milani J.N., Lavie C.J. The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention. Catheter Cardiovasc Interv 2009, 74:819-822.
13. Testa L., Van Gaal W.J., Biondi Zoccai G.G., Agostoni P., Latini R.A., Bedogni F., et al. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. QJM 2009, 102:369-378.
14. Yokoyama Y., Chaitman B.R., Hardison R.M., Guo P., Krone R., Stocke K., et al. Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac mortality in BARI randomized and registry patients. Am J Cardiol 2000, 86:819-824.
15. Saenger A.K., Jaffe A.S. Requiem for a heavyweight: the demise of creatine kinase-MB. Circulation 2008, 118:2200-2206.
16. Turer A.T., Addo T.A., Martin J.L., Sabatine M.S., Lewis G.D., Gerszten R.E., et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. J Am Coll Cardiol 2011, 57:2398-2405.
17. Mousavi N., Czarnecki A., Kumar K., Fallah-Rad N., Lytwyn M., Han S.Y., et al. Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol 2009, 103:1467-1472.
18. Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction. Eur Heart J 2007, 28:2525-2538.
19. Thygesen K., Alpert J.S., Jaffe A.S. Third universal definition of myocardial infarction. Eur Heart J 2012, (in press).
20. Prasad A., Herrmann J. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med 2011, 364:453-464.
21. Eggers K.M., Lind L., Venge P., Lindahl B. Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction?. Am J Cardiol 2009, 103:588-591.
22. Zimarino M., Cicchitti V., Genovesi E., Rotondo D., De Caterina R. Isolated troponin increase after percutaneous coronary interventions: does it have prognostic relevance?. Atherosclerosis 2012, 221:297-302.
23. Cavallini C., Verdecchia P., Savonitto S., Arraiz G., Violini R., Olivari Z., et al. Prognostic value of isolated troponin I elevation after percutaneous coronary intervention. Circ Cardiovasc Interv 2010, 3:431-435.
24. Bonaca M.P., Wiviott S.D., Braunwald E., Murphy S.A., Ruff C.T., Antman E.M., et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38). Circulation 2012, 125:577-583.
25. Hubacek J., Basran R.S., Shrive F.M., Shewchuk L., Goodhart D.M., Anderson T.J. Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention. Can J Cardiol 2009, 25:e42-e47.
26. Jeremias A., Kleiman N.S., Nassif D., Hsieh W.H., Pencina M., Maresh K., et al. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Circulation 2008, 118:632-638.
27. Locca D., Bucciarelli-Ducci C., Ferrante G., La Manna A., Keenan N.G., Grasso A., et al. New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions?. JACC Cardiovasc Interv 2010, 3:950-958.
28. Lim C.C., Van Gaal W.J., Testa L., Cuculi F., Arnold J.R., Karamitsos T., et al. With the "universal definition", measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention. J Am Coll Cardiol 2011, 57:653-661.
29. Grines C.L., Dixon S.R. A nail in the coffin of troponin measurements after percutaneous coronary intervention. J Am Coll Cardiol 2011, 57:662-663.
30. Baker J.O., Reinhold J., Redwood S., Marber M.S. Troponins: redefining their limits. Heart 2011, 97:447-452.
31. Porto I., Selvanayagam J.B., Van Gaal W.J., Prati F., Cheng A., Channon K., et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 2006, 114:662-669.
32. Zimarino M., Calafiore A.M., De Caterina R. Complete myocardial revascularization: between myth and reality. Eur Heart J 2005, 26:1824-1830.
33. Zimarino M., Ausiello A., Contegiacomo G., Riccardi I., Renda G., Di Iorio C., et al. Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions. J Am Coll Cardiol 2006, 48:59-65.
34. Prati F., Pawlowski T., Gil R., Labellarte A., Gziut A., Caradonna E., et al. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? A serial intravascular ultrasound study. Circulation 2003, 107:2320-2325.
35. Jaffe R., Charron T., Puley G., Dick A., Strauss B.H. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 2008, 117:3152-3156.
36. Iakovou I., Mintz G.S., Dangas G., Abizaid A., Mehran R., Kobayashi Y., et al. Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2003, 42:1900-1905.
37. Holmes D.R., Berger P.B. Troponisms, necrosettes, enzyme leaks, creatinine phosphokinase bumps, and infarctlets: what's behind this new lexicon and what does it add?. Circulation 2001, 104:627-629.
38. Akkerhuis K.M., Alexander J.H., Tardiff B.E., Boersma E., Harrington R.A., Lincoff A.M., et al. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?. Circulation 2002, 105:554-556.
39. Prasad A., Gersh B.J., Bertrand M.E., Lincoff A.M., Moses J.W., Ohman E.M., et al. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 2009, 54:477-486.
40. Chaitman B.R., Hardison R.M., Adler D., Gebhart S., Grogan M., Ocampo S., et al. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 2009, 120:2529-2540.
41. Damman P., Wallentin L., Fox K.A., Windhausen F., Hirsch A., Clayton T., et al. Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR). Circulation 2012, 125:568-576.
42. Janse M.J., Wit A.L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 1989, 69:1049-1169.
43. Zimarino M., Corazzini A., Tatasciore A., Marazia S., Torge G., Di Iorio C., et al. Defective recovery of QT dispersion predicts late cardiac mortality after percutaneous coronary intervention. Heart 2011, 97:466-472.